Profile data is unavailable for this security.
About the company
Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.
- Revenue in USD (TTM)185.49m
- Net income in USD-53.42m
- Incorporated2007
- Employees474.00
- LocationSilk Road Medical Inc1213 Innsbruck DrSUNNYVALE 94089-1317United StatesUSA
- Phone+1 (650) 566-9060
- Fax+1 (302) 655-5049
- Websitehttps://silkroadmed.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Varex Imaging Corp | 855.80m | 41.90m | 611.46m | 2.30k | 24.75 | 1.06 | 7.94 | 0.7145 | 0.604 | 0.604 | 16.18 | 14.10 | 0.7008 | 1.94 | 5.50 | 356,583.30 | 3.47 | 0.9913 | 4.03 | 1.18 | 32.39 | 31.70 | 4.95 | 1.36 | 2.37 | 2.57 | 0.4292 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
Fulgent Genetics Inc | 287.53m | -165.95m | 638.88m | 1.18k | -- | 0.5648 | -- | 2.22 | -5.57 | -5.57 | 9.64 | 37.80 | 0.2206 | -- | 6.01 | 242,846.30 | -13.29 | 16.70 | -14.16 | 18.37 | 37.47 | 67.89 | -60.25 | 29.06 | -- | -- | 0.0014 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
Paragon 28 Inc | 225.44m | -54.02m | 652.83m | 430.00 | -- | 3.97 | -- | 2.90 | -0.6536 | -0.6536 | 2.73 | 1.98 | 0.6956 | 0.5405 | 5.82 | 524,267.40 | -16.67 | -- | -20.52 | -- | 79.21 | -- | -23.96 | -- | 1.78 | -6.45 | 0.4018 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
Pulse Biosciences Inc | 0.00 | -42.55m | 659.39m | 56.00 | -- | 18.17 | -- | -- | -0.8152 | -0.8152 | 0.00 | 0.6571 | 0.00 | -- | -- | 0.00 | -71.28 | -93.21 | -79.29 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
Embecta Corp | 1.13bn | 70.20m | 782.58m | 2.20k | 11.16 | -- | 7.40 | 0.691 | 1.22 | 1.22 | 19.62 | -13.35 | 0.94 | 2.51 | 15.86 | 514,772.70 | 5.83 | -- | 8.06 | -- | 65.57 | -- | 6.20 | -- | 1.79 | 1.51 | 1.89 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
Cytek Biosciences Inc | 200.79m | -11.51m | 783.70m | 637.00 | -- | 2.00 | -- | 3.90 | -0.0856 | -0.0856 | 1.50 | 2.99 | 0.395 | 1.44 | 4.30 | 297,020.70 | -2.26 | -- | -2.54 | -- | 55.48 | -- | -5.73 | -- | 6.01 | -- | 0.0086 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
Orthopediatrics Corp | 161.83m | -21.97m | 789.93m | 247.00 | -- | 2.11 | -- | 4.88 | -0.9647 | -0.9647 | 7.11 | 15.74 | 0.3748 | 0.4247 | 5.13 | 655,178.10 | -5.09 | -5.40 | -5.62 | -5.93 | 74.07 | 75.09 | -13.58 | -15.92 | 1.99 | -- | 0.0271 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
Atrion Corp | 176.67m | 18.72m | 830.68m | 712.00 | 44.39 | 3.43 | 24.25 | 4.70 | 10.63 | 10.63 | 100.32 | 137.46 | 0.6794 | 1.56 | 7.93 | 248,127.80 | 7.20 | 11.96 | 7.63 | 12.62 | 33.77 | 41.99 | 10.60 | 19.05 | 3.06 | -- | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
Silk Road Medical Inc | 185.49m | -53.42m | 878.41m | 474.00 | -- | 5.96 | -- | 4.74 | -1.37 | -1.37 | 4.76 | 3.73 | 0.7247 | 2.08 | 7.87 | 391,322.80 | -20.87 | -29.02 | -22.75 | -32.98 | 73.31 | 72.91 | -28.80 | -46.84 | 9.62 | -- | 0.34 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
Avanos Medical Inc | 680.10m | -1.60m | 934.60m | 3.77k | -- | 0.7638 | 21.34 | 1.37 | -0.0315 | -1.33 | 14.62 | 26.65 | 0.4005 | 1.62 | 5.48 | 180,350.00 | -0.0942 | -0.6527 | -0.1055 | -0.7338 | 56.33 | 54.45 | -0.2353 | -1.60 | 1.47 | 4.85 | 0.1257 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
Artivion Inc | 368.21m | -9.58m | 991.61m | 1.50k | -- | 3.36 | 72.77 | 2.69 | -0.2615 | -0.2615 | 8.64 | 7.07 | 0.4779 | 1.64 | 5.37 | 245,470.70 | -1.25 | -2.20 | -1.33 | -2.36 | 64.75 | 65.51 | -2.61 | -5.34 | 4.26 | 2.26 | 0.5176 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
BioLife Solutions Inc | 137.30m | -62.93m | 1.01bn | 409.00 | -- | 3.00 | -- | 7.34 | -1.43 | -1.43 | 3.10 | 7.30 | 0.3238 | 2.17 | 5.61 | 335,687.00 | -14.84 | -13.76 | -16.52 | -15.04 | 32.97 | 36.76 | -45.84 | -42.99 | 1.77 | -32.08 | 0.0717 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
AtriCure Inc | 414.60m | -37.23m | 1.10bn | 1.20k | -- | 2.41 | -- | 2.65 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -10.27 | 0.1212 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
Coretag Inc | 0.00 | -34.52k | 1.13bn | 0.00 | -- | -- | -- | -- | -0.3806 | -0.3806 | 0.00 | -0.9801 | 0.00 | -- | -- | -- | -3,303.35 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
MiMedx Group Inc | 334.51m | 71.52m | 1.16bn | 895.00 | 20.84 | 7.44 | 14.54 | 3.46 | 0.3767 | 0.3393 | 2.15 | 1.06 | 1.72 | 2.82 | 6.58 | 373,754.20 | 41.80 | -4.14 | 53.13 | -5.90 | 83.50 | 83.61 | 24.36 | -2.70 | 2.71 | 9.00 | 0.111 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
Holder | Shares | % Held |
---|---|---|
Wasatch Advisors, Inc.as of 31 Mar 2024 | 4.55m | 11.61% |
Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 3.11m | 7.94% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 2.85m | 7.27% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 2.72m | 6.95% |
D. E. Shaw & Co. LPas of 31 Mar 2024 | 1.60m | 4.08% |
Bellevue Asset Management AGas of 31 Mar 2024 | 1.52m | 3.88% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 1.52m | 3.87% |
BAMCO, Inc.as of 31 Mar 2024 | 1.50m | 3.83% |
Tri Locum Partners LPas of 31 Mar 2024 | 1.08m | 2.77% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.04m | 2.65% |